Skip to Main Content

Contribute Try STAT+ Today

drug ads

Most Read

Watson on laptop

Health Tech By Casey Ross

The sale of Watson Health assets ends a dark chapter for IBM. For its buyer, the opportunity looks brighter

Pharmalot Coming/Going STILL

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Fall of Watson

Health Tech By Casey Ross

Once billed as a revolution in medicine, IBM’s Watson Health is sold off in parts

Pharmalot By Ed Silverman

Pharmalittle: Alzheimer’s patient groups to protest Medicare plan for Biogen drug; cancer combo treatments are questioned

First Opinion By Chenery Lowe, Liesl Broadbridge and Laynie Dratch

What genetic counselors can teach the CDC about communicating uncertainty

UCLA Hospital ICU virtuous cycle

First Opinion By Cynda Hylton Rushton, Ian Wolfe and Tener Goodwin Veenema

It’s staff, not stuff: Applying crisis standards of care to allocating health care workers

Health Tech By Mohana Ravindranath

For doctors drowning in emails, one health system’s new strategy: pay for replies

Michel Vounatsos

The Pharmalot View By Ed Silverman

If the Biogen CEO were truly ‘courageous,’ he would live with the Medicare decision

All Coverage

Entresto Ad

Business By Rebecca Robbins

Republican convention viewers sure saw a lot of drug ads

NON-24 TV Ad

As Seen on TV By Rebecca Robbins

Why is a company that makes a drug for blind people spending millions on TV ads?

advertisement

As Seen on TV By Rebecca Robbins

How Biogen went big to boost sales of its multiple sclerosis pill

Pharma TV Ad

Politics By Rebecca Robbins

At big drug ad conference, industry urged to fight ‘crescendo of criticism’

Pharmalot By Ed Silverman

Drug ads don’t prompt most consumers to ask about medicines

Hepatitis C virus model drug ad

First Opinion By Deborah Clark Dushane

You can complain about TV drug ads. They may have saved my life

drug ads Senior woman watching tv

Politics By Dylan Scott

The FDA wants to know how well older people understand TV drug ads

Pharma TV Ad

Exclusive By Rebecca Robbins

Drug makers now spend $5 billion a year on advertising. Here’s what that buys.

FDA

Business By Associated Press

FDA settlement allows firm to promote ‘off-label’ use of fish-oil drug

Pharmalot By Ed Silverman

Lawmaker seeks to end tax breaks for consumer drug ads

Pharmalot By Ed Silverman

Drug maker fined by New York over improper opioid marketing

Lamisil Ad

Pharmalot By Ed Silverman

FDA wants to know whether animated ads distort drug risks

Pharmaceutical ads

Pharmalot By Ed Silverman

Lawmaker seeks moratorium on consumer drug ads

Pharmalot By Ed Silverman

Drug makers stand firm on TV ad for opioid-induced constipation

Novartis Ad

Pharmalot By Ed Silverman

All wet: Novartis is slammed for ‘alarmist’ ad for heart failure drug